Prognostic Factors in Cancer / Edition 3

Paperback (Print)
Buy New
Buy New from BN.com
$107.95
Used and New from Other Sellers
Used and New from Other Sellers
from $28.54
Usually ships in 1-2 business days
(Save 76%)
Other sellers (Paperback)
  • All (6) from $28.54   
  • New (3) from $94.74   
  • Used (3) from $28.54   

Overview

Prognostic Factors in Cancer, Third Edition examines the prognostic factors associated with each cancer site and provides insight into potential treatments and therapies. The text is an extension of the International Union Against Cancer's (UICC) seminal work, the TNM Classification of Malignant Tumours, and integrates the current focus on prognostics in cancer.

This Third Edition reflects the advances in cancer diagnosis and treatment planning made in recent years. The first part of the book offers a complete update on the science of cancer prognosis while the second part contains site-specific chapters that provide evidence-based guidelines for treatment. Each clinical chapter summarizes the significance of the great variety of tumour-related, patient-related, and environment-related factors that play a role in the prognosis of cancer, all backed with a grid for quick reference.

Visit TNM Online at: www.mrw.interscience.wiley.com/tnm to find the complete text of the previous edition of Prognostic Factors in Cancer, as well as other supplemental material related to cancer staging and predictive indicators.

Prognostic Factors in Cancer, Third Edition is an invaluable resource for all oncologists and cancer researchers. The title is also of interest for other professionals such as pathologists and epidemiologists.

This book updates the first authoritative monograph on prognostic factors and their use in planning treatment for cancer patients. This text is an extension of studies undertaken by the International Union Against Cancer (UICC) in relation to their long-term work on the TNM Classification of Malignant Tumours. The TNM classification internationally is the most widely used system for staging the progression of cancer. The TNM system offers the most accurate tool for predicting outcomes for most tumour sites and certain tymour types. The chapters included contain an overview of the relevant literature and include summaries that classify the prognostic factors according to subject or topic, and relevance.

Read More Show Less

Editorial Reviews

From The Critics
Reviewer: Kenneth R. Carson, MD (Northwestern University Feinberg School of Medicine)
Description: This update provides a comprehensive review of the methods of determining prognosis and their clinical use with numerous tumor types.
Purpose: The intent with this new edition is to consolidate previous work in prognosis and prognostic factors, facilitating their use in clinical practice. These are worthy objectives, as patients with cancer and their physicians often struggle with providing realistic prognostic advice. Prognosis is often a lost art in the practice of modern, evidence-based medicine. The authors deliver exactly what they intended.
Audience: "This book is targeted at clinicians and researchers in the field of oncology. Each of the authors and editors is a credible authority in his or her respective field. "
Features: A well written description of the background and methods used to determine prognosis, including anatomic, histologic, and genetic prognostic factors, begins the book. The book is then divided into disease specific chapters with prognostic information related to each disease type. Each of these chapters contains a table for quick reference, which is helpful for busy clinicians.
Assessment: This is a well organized and reasonably comprehensive book. While the use of genetic prognostic factors is not explained comprehensively for all tumor types, the usefulness of this information is still being determined for many tumors. The book provides a quick reference that brings together state-of-the-art knowledge for numerous tumor types. The inclusion of genetic prognostic information for some tumor types as well as information on prognosis in the terminal setting, provides additional value in this third edition.
Read More Show Less

Product Details

  • ISBN-13: 9780470038017
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 6/16/2006
  • Edition description: REV
  • Edition number: 3
  • Pages: 353
  • Product dimensions: 6.04 (w) x 9.33 (h) x 0.78 (d)

Table of Contents

Preface.

Acknowledgements.

Contributors.

PART A. PRINCIPLES OF PROGNOSTIC FACTORS.

1. The Importance of Prognosis in Cancer Medicine (William Mackillop).

2. Principles of Documenting Prognosis and Prognostic Factors in Cancewr (Mary Gospodarowicz, Brian O’Sullivan and Eng-Siew Koh).

3. Studies Investigating Prognostic Factors: Conduct and Evaluation (Douglas Altman).

4. Prognostic Factors in Population Based Cancer Control (Patti Groome).

5. Prognostic Factors in Terminal Cancer (Paul Glare).

6. Incorporating Molecular Oncology into Prognosis (Geoffrey Liu, Wei Zhou, Zhaoxi Wang and Howard McLeod).

PART B. PROGNOSTIC FACTORS IN SPECIFIC CANCERS.

SECTION 1. HEAD AND NECK TUMORS (BRIAN O’SULLIVAN).

7. Oral Cavity, Pharynx, and Larynx Cancer (Jean Bourhis).

8. Paranasal Sinus Cancer (John Waldron).

9. Nasopharyngeal Cancer (Joseph wee and Eng Huat Tan).

10. Salivary Gland Cancer (Adam Garden).

11. Thyroid Cancer (James Brierley and Sylvia Asa).

SECTION 2. DIGESTIVE SYSTEM TUMORS (FREDERICK GREENE AND CHRISTIAN WITTEKIND).

12. Esophagus Cancer (Hubert J. Stein).

13. Gastric Cancer (Burkhand von Rahden).

14. Colorectal Cancer (JHJM van Krieken and Cornelis van de Velde).

15. Anal cancer (Bernard Cummings).

16. Hepatocellular Cancer (Philip Johnson and Daniel Palmer).

17. Extrahepatic Biliary Tract and the Ampulla of Vater Cancers (Christian Wittekind).

18. Pancreas Cancer (John Neoptolemos and Paula Ghaneh).

SECTION 3. LUNG AND PLEURAL TUMORS (CHRISTIAN WITTEKIND AND PATTI GROOME).

19. Lung Cancer (Michael Brundage and William Mackillop).

20. Malignant Pleural Mesothelioma (Richard Battafarano and N. K. Veeramachaneni).

21. Malignant Thymoma (Andrea Bezjak and David G. Payne).

SECTION 4. TUMORS OF BONE AND SOFT TISSUES (BRIAN O’SULLIAN).

22. Osteosarcoma (Henrik C. F. Bauer).

23. Soft Tissue Sarcoma (Charles Catton and Brian O’Sullivan).

24. Gastrointestinal Stromal Tumors (Jaap Verweij and Stefan Sleijfer).

SECTION 5. SKIN TUMORS (LESLIE SOBIN).

25. Skin Cancer (Michael Poulsen).

26. Cutaneous Malignant Melanoma (Peter J. Heenan and Trevor Beer).

SECTION 6. BREAST CANCER (FREDERICK GREENE).

27. Breast Cancer (Daniel F. Hayes).

SECTION 7. GYNECOLOGIC CANCERS (MARY GOSPODAROWICZ).

28. Vulvar Cancer (Neville Hacker and Donald Marsden).

29. Uterine Cervix Cancer (Jan Hauspy, Ian Harley and Anthony Fyles).

30. Ovarian and Fallopian TubeCancer (Sergio Pecorelli, Brunella Pasinetti, Giancarlo, Lucia Zigliani and Franco E. Odicino).

31. Endometrial Cancer (Michael Milosevi and Fernanda Herrera).

32. Gestational Trophoblastic Disease (Hextan Ngan, Karen K.L. Chan and Kevin F. Tan).

SECTION 8. UROLOGICAL TUMORS (MARY GOSPODAROWICZ).

33. Penile Cancer (Simon Horenblas and Juanita Crook).

34. Prostate cancer (Louis Denis and Padraig Warde).

35. Germ Cell Tests Tumors (Hans-Joachim Schmoll and Peter Chung).

36. Renal Cell Cancer (Christophe Ghysel, Steven Joniau and Heindrik Van Poppel).

37. Bladder cancer (Adrian van der Meijden and Richard Sylvester).

SECTION 9. OPHTHALMIC TUMORS (LES SOBIN).

38. Uveal Melanoma Tumors (Jerry Shields and Carol Shields).

39. Retinoblastoma (Vikas Khetan, Helen S. L. Chan, Lisa Wang and Brenda L. Gallie).

SECTION 10. HEMATOLOGIC MALIGNANCIES (MARY GOSPODAROWICZ).

40. Hodgkin Lymphoma (Lena Specht).

41. Non-Hodgkin Lymphoma (M. Gospodarowicz, M. Crump and E. Zucca).

42. Leukemia (Mark Minden, P. Disperati, F. Suarez-Saiz and H. Khoury).

43. Multiple Myeloma (Jesus San Miguel and Norma C. Guti43. Multiple Myeloma (Jesus San Miguel and Norma C. Gutierrez).

SECTION 11. BRAIN TUMORS (BRIAN O’SULLIVAN).

44. Gliomas (Michael Brada, Paul Kleihues, Guiseppe Minniti and Hiroko Ohgaki).

SECTION 12. PEDIATRIC TUMORS (FREDERICK GREENE).

45. Pediatric Cancers (Eric Bouffet, David C. Hodgson and Eng-Siew Koh).

Epilogue.

Glossary.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)